Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 36.93 at 1:00 pm ET, low 36.68 at 3:45 pm ET.
the bull case· 1
214
managers reporting a position in thirteen F filings
13fJun 30 '26the bear case· 4
3
of the funds on file reporting a position in BLFS
n-portas of Jun 30 '260.04%
of iShares Russell two thousand ETF assets as the largest fund weight on file
n-portJun 30 '269 of 23
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26−4.06%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 12 '26 report. Not a forecast, not advice.
Of the 6 companies Biolife Solutions Inc moves with most closely, none share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3845, Electromedical & Electrotherapeutic Apparatus, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
Biolife Solutions Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
214 managers report a position worth $1.4B between them, and 28 of them hold 80% of it.
BLFS (Biolife Solutions Inc) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.